Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
European Journal of Radiology|March 21, 2021
Correct determination of the enhancement curve is critical to ensure accurate diagnosis using the Kaiser score as a clinical decision rule for breast MRICristina Grippo, Pooja Jagmohan, Thomas H Helbich, et al.
Plos One|September 9, 2016
Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast CancerBarbara Bennani-Baiti, Matthias Dietzel, Pascal A Baltzer
Evaluation Review|August 22, 2018
RD or Not RD: Using Experimental Studies to Assess the Performance of the Regression Discontinuity ApproachPhilip Gleason, Alexandra Resch, Jillian Berk
Acta Radiologica (Stockholm, Sweden : 1987)|August 17, 2010
Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classesMatthias Benndorf, Pascal A T Baltzer, Tibor Vag, et al.
Breast (Edinburgh, Scotland)|February 22, 2021
Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysisBarbara J Fueger, Paola Clauser, Panagiotis Kapetas, et al.
European Journal of Radiology|October 20, 2024
MRI-only breast cancers are less aggressive than cancers identifiable on conventional imagingMelis Baykara Ulusan, Francesca Ferrara, Emine Meltem, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 25, 2022
Evidence-Based and Structured Diagnosis in Breast MRI using the Kaiser ScorePascal Andreas Thomas Baltzer, Kathrin Barbara Krug, Matthias Dietzel
European Journal of Radiology|April 28, 2020
Can second-look ultrasound downgrade MRI-detected lesions? A retrospective studyMichael Kolta, Paola Clauser, Panagiotis Kapetas, et al.
Current Breast Cancer Reports|May 2, 2022
Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk AssessmentGeorg J Wengert, Thomas H Helbich, Doris Leithner, et al.
European Journal of Radiology|August 2, 2024
A model combining BI-RADS® descriptors from pre-treatment B-mode breast ultrasound with clinicopathological tumor features shows promise in the prediction of residual disease after neoadjuvant chemotherapyPanagiotis Kapetas, Reena Aggarwal, Basmah Altuwayjiri, et al.
Pageof 23